{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:43:52Z","timestamp":1777463032657,"version":"3.51.4"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AR"],"DOI":"10.21873\/anticanres.12243","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T16:08:17Z","timestamp":1514909297000},"source":"Crossref","is-referenced-by-count":3,"title":["Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients"],"prefix":"10.21873","volume":"38","member":"9336","published-online":{"date-parts":[[2018,1,2]]},"container-title":["Anticancer Research"],"original-title":[],"link":[{"URL":"http:\/\/ar.iiarjournals.org\/content\/38\/1\/449.full.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:58:29Z","timestamp":1524020309000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/content\/38\/1\/449.abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,2]]}},"URL":"https:\/\/doi.org\/10.21873\/anticanres.12243","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"value":"0250-7005","type":"print"},{"value":"1791-7530","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]}}}